On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Podcast: Non-Competes in 2026 - FTC Signals Major Policy Shift – Employment Law This Week
- In Lawsuits, Facts Matter. Employers That Embrace DEI Can Weather the Storm
- Video: NLRB Shifts Enforcement, DOL’s Non-Union Focus, and EEOC’s DEI Crackdown - Employment Law This Week
- After Ames, the Third Circuit Ends New Jersey’s Background Circumstances Rule for Reverse Discrimination Claims
- SEC Issues New Guidance Under Rule 701 for Employee Equity Compensation